Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07535827) titled 'Insulin Intratympanic Application' on April 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).

Primary Sponsor: Deraya University

Condition: Tympanic Membrane Perforation

Intervention: Drug: Insulin (Humulin)

Recruitment Status: Recruiting

Phase: Early Phase 1

Date of First Enrollment: March 20, 2026

Target Sample Size: 25

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07535827

Disclaimer: Curated by HT Syndication....